Groeneveld CS, Fontugne J, Cabel L, Bernard-Pierrot I, et al. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy. Eur J Cancer 2021;148:181-189.
PMID: 33743486